Literature DB >> 23557184

Dose- and time-dependent neuroprotective effects of Pycnogenol following traumatic brain injury.

Mubeen A Ansari1, Kelly N Roberts, Stephen W Scheff.   

Abstract

After traumatic brain injury (TBI), both primary and secondary injury cascades are initiated, leading to neuronal death and cognitive dysfunction. We have previously shown that the combinational bioflavonoid, Pycnogenol (PYC), alters some secondary injury cascades and protects synaptic proteins when administered immediately following trauma. The purpose of the present study was to explore further the beneficial effects of PYC and to test whether it can be used in a more clinically relevant fashion. Young adult male Sprague-Dawley rats were subjected to a unilateral moderate/severe cortical contusion. Subjects received a single intravenous (i.v.) injection of PYC (1, 5, or 10 mg/kg) or vehicle, with treatment initiated at 15 min, 2 h, or 4 h post injury. All rats were killed at 96 h post TBI. Both the cortex and hippocampus ipsilateral and contralateral to the injury were evaluated for possible changes in oxidative stress (thiobarbituric acid reactive species; TBARS) and both pre- and post-synaptic proteins (synapsin-I, synaptophysin, drebrin, post synaptic density protein-95, and synapse associated protein-97). Following TBI, TBARS were significantly increased in both the injured cortex and ipsilateral hippocampus. Regardless of the dose and delay in treatment, PYC treatment significantly lowered TBARS. PYC treatment significantly protected both the cortex and hippocampus from injury-related declines in pre- and post-synaptic proteins. These results demonstrate that a single i.v. treatment of PYC is neuroprotective after TBI with a therapeutic window of at least 4 h post trauma. The natural bioflavonoid PYC may provide a possible therapeutic intervention in neurotrauma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23557184      PMCID: PMC3751204          DOI: 10.1089/neu.2013.2910

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  61 in total

1.  Nutrition and traumatic brain injury: a perspective from the Institute of Medicine report.

Authors:  Bruce Ryan Bistrian; Wayne Askew; John W Erdman; Maria P Oria
Journal:  JPEN J Parenter Enteral Nutr       Date:  2011-09       Impact factor: 4.016

2.  Diffuse prolonged depression of cerebral oxidative metabolism following concussive brain injury in the rat: a cytochrome oxidase histochemistry study.

Authors:  D A Hovda; A Yoshino; T Kawamata; Y Katayama; D P Becker
Journal:  Brain Res       Date:  1991-12-13       Impact factor: 3.252

3.  (-)-Epigallocatechin-3-gallate protects against neuronal cell death and improves cerebral function after traumatic brain injury in rats.

Authors:  Tatsuki Itoh; Motohiro Imano; Shozo Nishida; Masahiro Tsubaki; Shigeo Hashimoto; Akihiko Ito; Takao Satou
Journal:  Neuromolecular Med       Date:  2011-10-25       Impact factor: 3.843

Review 4.  The MAPK signaling cascade.

Authors:  R Seger; E G Krebs
Journal:  FASEB J       Date:  1995-06       Impact factor: 5.191

5.  GSK3β inhibition is involved in the neuroprotective effects of cyclin-dependent kinase inhibitors in neurons.

Authors:  Aurelio Vazquez de la Torre; Felix Junyent; Jaume Folch; Carme Pelegrí; Jordi Vilaplana; Carme Auladell; Carlos Beas-Zarate; Mercè Pallàs; Ester Verdaguer; Antoni Camins
Journal:  Pharmacol Res       Date:  2011-08-22       Impact factor: 7.658

6.  Neuroprotection by resveratrol against traumatic brain injury in rats.

Authors:  Ozkan Ates; Suleyman Cayli; Eyup Altinoz; Iclal Gurses; Neslihan Yucel; Metin Sener; Ayhan Kocak; Saim Yologlu
Journal:  Mol Cell Biochem       Date:  2006-08-19       Impact factor: 3.396

7.  Delayed growth of glioma by Scutellaria flavonoids involve inhibition of Akt, GSK-3 and NF-κB signaling.

Authors:  Prahlad Parajuli; N Joshee; S R Chinni; A M Rimando; S Mittal; S Sethi; A K Yadav
Journal:  J Neurooncol       Date:  2010-05-14       Impact factor: 4.130

8.  Akt phosphorylation is required for heat acclimation-induced neuroprotection.

Authors:  Na'ama A Shein; Jeanna Tsenter; Alexander G Alexandrovich; Michal Horowitz; Esther Shohami
Journal:  J Neurochem       Date:  2007-08-23       Impact factor: 5.372

9.  Neuronal NOS-mediated nitration and inactivation of manganese superoxide dismutase in brain after experimental and human brain injury.

Authors:  Hülya Bayir; Valerian E Kagan; Robert S B Clark; Keri Janesko-Feldman; Ruslan Rafikov; Zhentai Huang; Xiaojing Zhang; Vincent Vagni; Timothy R Billiar; Patrick M Kochanek
Journal:  J Neurochem       Date:  2007-04       Impact factor: 5.372

Review 10.  The duality of the inflammatory response to traumatic brain injury.

Authors:  P M Lenzlinger; M C Morganti-Kossmann; H L Laurer; T K McIntosh
Journal:  Mol Neurobiol       Date:  2001 Aug-Dec       Impact factor: 5.682

View more
  11 in total

Review 1.  Vitamins and nutrients as primary treatments in experimental brain injury: Clinical implications for nutraceutical therapies.

Authors:  Cole Vonder Haar; Todd C Peterson; Kris M Martens; Michael R Hoane
Journal:  Brain Res       Date:  2015-12-23       Impact factor: 3.252

2.  Microwave & Magnetic (M2) Proteomics of a Mouse Model of Mild Traumatic Brain Injury.

Authors:  Teresa M Evans; Holly Van Remmen; Anjali Purkar; Swetha Mahesula; J Al Gelfond; Marian Sabia; Wenbo Qi; Ai-Ling Lin; Carlos A Jaramillo; William E Haskins
Journal:  Transl Proteom       Date:  2014-06-01

3.  Cognitive assessment of pycnogenol therapy following traumatic brain injury.

Authors:  Stephen W Scheff; Kelly N Roberts
Journal:  Neurosci Lett       Date:  2016-10-11       Impact factor: 3.046

Review 4.  Natural Compounds as a Therapeutic Intervention following Traumatic Brain Injury: The Role of Phytochemicals.

Authors:  Stephen W Scheff; Mubeen A Ansari
Journal:  J Neurotrauma       Date:  2016-12-21       Impact factor: 5.269

5.  Blast waves from detonated military explosive reduce GluR1 and synaptophysin levels in hippocampal slice cultures.

Authors:  Marquitta Smith; Thuvan Piehler; Richard Benjamin; Karen L Farizatto; Morgan C Pait; Michael F Almeida; Vladimir V Ghukasyan; Ben A Bahr
Journal:  Exp Neurol       Date:  2016-10-05       Impact factor: 5.330

6.  Pycnogenol protects CA3-CA1 synaptic function in a rat model of traumatic brain injury.

Authors:  Christopher M Norris; Pradoldej Sompol; Kelly N Roberts; Mubeen Ansari; Stephen W Scheff
Journal:  Exp Neurol       Date:  2015-11-29       Impact factor: 5.330

Review 7.  Novel therapeutic strategies for traumatic brain injury: acute antioxidant reinforcement.

Authors:  Rodrigo Fernández-Gajardo; José Manuel Matamala; Rodrigo Carrasco; Rodrigo Gutiérrez; Rómulo Melo; Ramón Rodrigo
Journal:  CNS Drugs       Date:  2014-03       Impact factor: 5.749

8.  A time course of NADPH-oxidase up-regulation and endothelial nitric oxide synthase activation in the hippocampus following neurotrauma.

Authors:  Mubeen A Ansari; Kelly N Roberts; Stephen W Scheff
Journal:  Free Radic Biol Med       Date:  2014-09-16       Impact factor: 7.376

Review 9.  Psychiatric Disorders and Polyphenols: Can They Be Helpful in Therapy?

Authors:  Jana Trebatická; Zdeňka Ďuračková
Journal:  Oxid Med Cell Longev       Date:  2015-06-09       Impact factor: 6.543

10.  Blockade of Astrocytic Calcineurin/NFAT Signaling Helps to Normalize Hippocampal Synaptic Function and Plasticity in a Rat Model of Traumatic Brain Injury.

Authors:  Jennifer L Furman; Pradoldej Sompol; Susan D Kraner; Melanie M Pleiss; Esther J Putman; Jacob Dunkerson; Hafiz Mohmmad Abdul; Kelly N Roberts; Stephen W Scheff; Christopher M Norris
Journal:  J Neurosci       Date:  2016-02-03       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.